These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 6803298)

  • 1. Management of inhibitors to factor VIII.
    Kasper CK
    Prog Hematol; 1981; 12():143-63. PubMed ID: 6803298
    [No Abstract]   [Full Text] [Related]  

  • 2. Current treatment of patients with inhibitors to factor VIII.
    Hilgartner MW
    Haematologia (Budap); 1986; 19(1):21-32. PubMed ID: 3087840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Substitution therapy of coagulopathies].
    Beeser H; Egli H
    Infusionstherapie (1973); 1974 Aug; 1(6):447-53. PubMed ID: 4466806
    [No Abstract]   [Full Text] [Related]  

  • 4. Combined factor VIII and IX inhibitors in a non-haemophilic patient: successful treatment with immunosuppressive drugs.
    Carmassi F; Giannarelli C; De Giorgi A; De Negri F
    Haemophilia; 2007 Jan; 13(1):106-7. PubMed ID: 17212735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in diagnosis and treatment of hemophilia and related diseases.
    Langdell AD
    CRC Crit Rev Clin Lab Sci; 1970 Dec; 1(4):585-98. PubMed ID: 4939756
    [No Abstract]   [Full Text] [Related]  

  • 6. The physiologic basis for therapy of classic hemophilia (factor 8 deficiency) and related disorders. Combined clinical staff conference at the National Institutes of Health.
    Ann Intern Med; 1967 Oct; 67(4):856-82. PubMed ID: 5299081
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibitor development in haemophiliacs: theoretical background and clinical aspects.
    Sultan Y
    Blood Coagul Fibrinolysis; 1995 Jul; 6 Suppl 2():S55-7. PubMed ID: 7495970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recombinant activated Factor VII (Novoseven Novo Nordisk) for hemostasis in acquired Factor VIII-inhibitor hemophilia].
    Meili EO; Dazzi H; von Felten A
    Schweiz Med Wochenschr; 1995 Mar; 125(9):405-11. PubMed ID: 7892567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunosuppressive treatment of a spontaneous inhibitor hemophilia A using cyclophosphamide, vincristine and prednisone following prior Factor VIII stimulation].
    Dürig J; de Wit M; Fiedler W; Marx G; Hossfeld DK
    Schweiz Med Wochenschr; 1996 Nov; 126(47):2026-31. PubMed ID: 8984611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proceedings: Prothrombin-complex concentrates, thromboses, and factor VIII inhibitors: evidence for a coagulant formed by the interaction of factors X and II.
    Tishkoff GH
    Thromb Diath Haemorrh; 1975 Nov; 34(2):589. PubMed ID: 1198500
    [No Abstract]   [Full Text] [Related]  

  • 11. The treatment of patients having spontaneously occurring antibodies to antihaemophilic factor (factor VIII).
    Rizza CR; Edgcumbe JO; Pitney WR; Child JA
    Thromb Diath Haemorrh; 1972 Aug; 28(1):120-8. PubMed ID: 5074988
    [No Abstract]   [Full Text] [Related]  

  • 12. [Factor VIII inhibitors].
    Albores Núñez MI; Pérez Llanderal JA; Telenti Vigón A
    Rev Clin Esp; 1968 Apr; 109(2):129-36. PubMed ID: 5739637
    [No Abstract]   [Full Text] [Related]  

  • 13. [Successful induction of immune tolerance and novel hemostatic effects in a hemophilia A with high-responder inhibitor by regular infusions of factor VIII].
    Shima M; Sawamoto Y; Kamisue M; Shibata Y; Tuzi S; Kuwabara M; Tanaka I; Tanizawa T; Tanaka A; Ueda M; Kakishita E; Yoshioka A
    Rinsho Ketsueki; 1996 Nov; 37(11):1303-8. PubMed ID: 8960666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquired hemophilia.
    Bouvry P; Recloux P
    Haematologica; 1994; 79(6):550-6. PubMed ID: 7896216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracorporeal immunoadsorption for the treatment of coagulation inhibitors.
    Franchini M; Sassi M; Dell'Anna P; Manzato F; Salvagno GL; Montagnana M; Zaffanello M; Targher G; Lippi G
    Semin Thromb Hemost; 2009 Feb; 35(1):76-80. PubMed ID: 19308895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemophilia. Strategies for the treatment of inhibitor patients.
    Ingerslev J
    Haematologica; 2000 Oct; 85(10 Suppl):15-20. PubMed ID: 11187863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current management of acquired factor VIII inhibitors.
    Barnett B; Kruse-Jarres R; Leissinger CA
    Curr Opin Hematol; 2008 Sep; 15(5):451-5. PubMed ID: 18695367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma exchange for coagulopathy and/or coagulation inhibitors.
    Spero JA
    J Clin Apher; 1985; 2(4):278-81. PubMed ID: 3934146
    [No Abstract]   [Full Text] [Related]  

  • 19. A simple procedure for accurate quantitation of factor VIII inhibitors.
    Tse D; Fekete L; Shanbrom E
    Thromb Diath Haemorrh; 1970 Feb; 23(1):19-25. PubMed ID: 5420431
    [No Abstract]   [Full Text] [Related]  

  • 20. Strategies to promote hemostasis in patients with F VIII inhibitors.
    Lusher JM
    Prog Clin Biol Res; 1990; 324():39-46. PubMed ID: 2106691
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.